3 completed, 1 active not recruiting, 1 enrolling by invitation, 1 recruiting. 3 Not applicable, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 3 | Active not recruiting 1, Completed 1, Enrolling by invitation 1 |
| Phase 3 | 1 | Completed 1 |
Follow Juvenile Idiopahtic Arthritis: new trials by email Literature Review of Juvenile Idiopahtic Arthritis trials Research Report on Juvenile Idiopahtic Arthritis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| VR for Steroid Joint Injections - Feasibility VR-PAT - Acute Pain, Procedural Anxiety | Not applicable | Enrolling by invitation | Nationwide Children's Hospital | 10 | 2026-10-08 | 2026-10-20 |
| Cardiovascular Risk in Children With Chronic Conditions Study Kidney Transplant, Familial Hypercholesterolaemia | Recruiting | Semmelweis University | 300 | 2025-04-01 | 2025-08-08 | |
| 30-Second Sit-to-Stand Test for Assessing Functional Capacity in Juvenile Idiopathic Arthritis Juvenile Idiopahtic Arthritis | Completed | Istanbul University - Cerrahpasa | 192 | 2024-09-30 | 2026-10-20 | |
| JIA Toolbox Feasibility Study Heating prototype (Prototype 1), Physio tool (Prototype 2), Communication tool (Prototype 3) - Juvenile Idiopahtic Arthritis | Not applicable | Active not recruiting | Sheffield Children's NHS Foundation Trust | 25 | 2024-05-21 | 2026-04-22 |
| Improving Outcomes for Juvenile Idiopathic Arthritis The intervention was a one year support program JASP-1 - Juvenile Idiopahtic Arthritis | Not applicable | Completed | Region Stockholm | 116 | 2019-08-15 | 2026-06-22 |
| Extension Study Evaluating Etanercept in 3 Subtypes of Childhood Arthritis etanercept - Juvenile Idiopahtic Arthritis | Phase 3 | Completed | Pfizer | 109 | 2011-10-10 | 2022-11-14 |
Acute Pain (1) · Aortic Coarctation (1) · Aortic Valve Stenosis (1) · Arthritis, Psoriatic (1) · Diabetes Mellitus, Type 1 (1) · Diabetes Mellitus, Type 2 (1) · HIV Infections (1) · Hyperlipoproteinemia Type II (1) · Hypertension (1) · Hypertension, Pulmonary (1) · Inflammatory Bowel Diseases (1) · Leukemia (1) · Lymphoma (1) · Mucocutaneous Lymph Node Syndrome (1) · Neoplasms (1)
Pathological Conditions, Signs and Symptoms (2) · Signs and Symptoms (2) · Skin Diseases (2) · Skin and Connective Tissue Diseases (2) · Aortic Valve Disease (1) · Arthritis (1) · Autoimmune Diseases (1) · Blood-Borne Infections (1) · Body Weight (1) · Bone Diseases (1) · Cardiovascular Abnormalities (1) · Cardiovascular Diseases (1) · Chronic Disease (1) · Communicable Diseases (1) · Congenital Abnormalities (1)
Etanercept (1)
Istanbul University - Cerrahpasa (1) · Nationwide Children's Hospital (1) · Pfizer (1) · Region Stockholm (1) · Semmelweis University (1) · Sheffield Children's NHS Foundation Trust (1)
Hungary (2) · Australia (1) · Belgium (1) · Colombia (1) · Czechia (1) · France (1) · Germany (1) · Italy (1) · Latvia (1) · Lithuania (1) · Mexico (1) · Netherlands (1) · Norway (1) · Poland (1) · Russia (1)
Asena Yekdaneh, MSc. Pt. (1) · Asya Albayrak, MSc. Pt. (1) · Nilay Arman, Assoc. Prof. (1) · Nuray Aktay Ayaz, Prof. (1) · Tamas Kiss, MD, PhD (1) · Ursula Ankeny (1)